![Georg Buchner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Georg Buchner worked as a Vice President in Business Development at Silence Therapeutics Plc from 2011 to 2012.
Prior to that, he held the same position at PolyTherics Ltd. and Novacta Biosystems Ltd. He was also a Manager of Business Development at PharmaVentures Ltd. in 2013.
Before his career in business, he earned a doctorate from King's College London and an MBA from the University of Cambridge.
Eerdere bekende functies van Georg Buchner
| Bedrijven | Functie | Einde |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Corporate Officer/Principal | 01-06-2012 |
PharmaVentures Ltd.
 PharmaVentures Ltd. Investment ManagersFinance Provides advising services on life sciences transactions | Corporate Officer/Principal | - |
PolyTherics Ltd.
 PolyTherics Ltd. Pharmaceuticals: MajorHealth Technology Develops biomedical polymers for therapeutic applications | Corporate Officer/Principal | - |
Haptogen Ltd.
 Haptogen Ltd. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Corporate Officer/Principal | - |
Novacta Biosystems Ltd.
 Novacta Biosystems Ltd. BiotechnologyHealth Technology Discovers and develops drugs for treatment of bacterial infections | Corporate Officer/Principal | - |
Opleiding van Georg Buchner
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
2
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
PharmaVentures Ltd.
PharmaVentures Ltd. Investment ManagersFinance Provides advising services on life sciences transactions | Finance |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacta Biosystems Ltd.
Novacta Biosystems Ltd. BiotechnologyHealth Technology Discovers and develops drugs for treatment of bacterial infections | Health Technology |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Haptogen Ltd.
Haptogen Ltd. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
PolyTherics Ltd.
PolyTherics Ltd. Pharmaceuticals: MajorHealth Technology Develops biomedical polymers for therapeutic applications | Health Technology |
